Korean Journal of Ophthalmology10.3341/kjo.2012.26.5.3782012265378Effect of Amiloride to Retinal Toxicity Induced by Tissue Plasminogen ActivatorUngsoo Samuel Kim, Hyun-Sub Oh, Oh Woong Kwon, In Chung, Sung-Ho Lee, Joon Haeng Lee,,
Journal of the Korean Ophthalmological Society10.3341/jkos.2009.50.5.8002009505800Retinal Toxicity of Intravitreal Tissue Plasminogen Activator on Submacular HemorrhageJong Jin Jung, Sung Won Cho,,
Ophthalmology10.1016/s0161-6420(02)01979-620031104704-708Retinal toxicity of intravitreal tissue plasminogen activatorSan-Ni Chen, Te-Cheng Yang, Cheng-Lien Ho, Ya-Hui Kuo, Yeung Yip, An-Ning Chao,
Ophthalmology10.1016/s0161-6420(99)90565-11999106122231Tissue plasminogen activator after retinal artery occlusionMichael F Marmor,
Fibrinolysis10.1016/0268-9499(89)90133-11989324Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor-1 by cultured human retinal endothelial cells: Modulation by insulin-like growth factor 1Maria B. Grant, Colleen Guey,
Fibrinolysis10.1016/0268-9499(94)90234-81994822-24The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitusB. Myrup, P. Rossing, T. Jensen, J. Gram, C. Kluft, J. Jespersen,
Ophthalmology10.1016/s0161-6420(99)90547-x1999106122231-2232Tissue plasminogen activator after retinal artery occlusion: Author’s replyGisbert Richard,
Graefe's Archive for Clinical and Experimental Ophthalmology10.1007/s00417-007-0670-x20072464509-514Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion modelTakuhiro Yamamoto, Motohiro Kamei, Paradee Kunavisarut, Mihoko Suzuki, Yasuo Tano,,
Thrombosis Research10.1016/0049-3848(89)90394-01989555619-625Tissue plasminogen activator-induced secretion of type-1 plasminogen activator inhibitor in cultured human fibroblastsT.M. Reilly, G. Greenplate, P.B.M.W.M. Timmermans,
Fibrinolysis10.1016/s0268-9499(96)80499-1199610120413 The effect of plasminogen activator inhibitor (PAI-1) released from washed platelets on the amidolytic activity of tissue-type plasminogen activator (t-PA),